ArticlePolymers2022
Development of Biodegradable Composites Using Polycaprolactone and Bamboo Powder.
Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- From Waste to Value: Fruit Biofillers in Biodegradable Composite Materials.Biomimetics (Basel, Switzerland) · 2026Article
- Improved Toughness of PLA/PBAT/Modified Bamboo Powder Composites Through Interfacial Regulation.Materials (Basel, Switzerland) · 2026Article
- Computational and molecular docking analysis of a novel azo compound and its nanocomposite biopolymer synthesized via a single-pot method.Scientific reports · 2025Article
- Evaluation of Medical-Grade Polycaprolactone for 3D Printing: Mechanical, Chemical, and Biodegradation Characteristics.Polymers · 2025Article
- Early Biological Response to Poly(ε-caprolactone) PCL-Bioactive Glass Composites Obtained by 3D Printing as Bone Substitutes.Polymers · 2025Article
- Biocompatible Thermoplastics in Additive Manufacturing of Bone Defect Fillers: State-of-the-Art and Future Prospects.Materials (Basel, Switzerland) · 2025Review
- Synthesis and Morphology Characteristics of New Highly Branched Polycaprolactone PCL.Molecules (Basel, Switzerland) · 2024Article
- The Effect of Various Ti6Al4V Powders on the Behavior of Particle-Reinforced Polyester Matrix Composites.Polymers · 2023Article
- Article
- Bio-Based Polyurethane Foams for the Removal of Petroleum-Derived Pollutants: Sorption in Batch and in Continuous-Flow.Polymers · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of biodegradable polymers in daily life is increasing to reduce environmental hazards. In line with this, the present study aimed to develop a fully biodegradable polymer composite that was environmentally friendly and exhibited promising mechanical and thermal properties. Bamboo powder (BP)-reinforced polycaprolactone (PCL) composites were prepared using the solvent casting method. The influence of BP content on the morphology, wettability, and mechanical and thermal properties of the neat matrix was evaluated. In addition, the degradation properties of the composites were analysed through soil burial and acidic degradation tests. It was revealed that BP contents had an evident influence on the properties of the composites. The increase in the BP content has significantly improved the tensile strength of the PCL matrix. A similar trend is observed for thermal stability. Scanning electron micrographs demonstrated uniform dispersion of the BP in the PCL matrix. The degradation tests revealed that the biocomposites with 40 wt·% of BP degraded by more than 20% within 4 weeks in the acidic degradation test and more than 5% in the soil burial degradation test. It was noticed that there was a considerable difference in the degradation between the PCL matrix and the biocomposites of PCL and BP. These results suggest that biodegradable composites could be a promising alternative material to the existing synthetic polymer composites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.